HEADACHE & MIGRAINE THERAPIES

Relief is within reach: Synergy’s integrative approach to headache and migraine treatment

Note: The treatments mentioned below are covered by your medical benefits & Alberta Health.

Individuals who suffer from chronic headaches, migraines, and temporomandibular joint (TMJ) disorders may experience disruptions to their employment, relationships, and overall quality of life. Research indicates that Calgary, Cochrane, and neighboring regions exhibit a higher incidence of these conditions. Fortunately, there exist several effective and safe treatment modalities available to address and alleviate these symptoms. These options include preventative and abortive medications, supplements, biological agents, and therapeutic Botox injections. At Synergy, our treatment approach extends beyond medication and injections, taking into account various factors such as psychological, musculoskeletal, and functional contributions to a patient’s condition. Through this integrative approach, we aim to provide comprehensive care tailored to each individual’s unique needs.

At Synergy, we offer Botox injections as an effective and proven method to alleviate the chronic pain associated with headaches and migraines. Our skilled and experienced medical professionals use a precise and targeted approach to administer Botox, providing long-lasting relief from symptoms. In addition to Botox injections, we also take a comprehensive and integrative approach to treatment and our team of experts works together to create a personalized treatment plan for each patient to ensure optimal results and overall well-being.

BOTOX TREATMENT ®

BOTOX® Migraine injections can reduce your migraines’ frequency, duration, and intensity by 80% by the third treatment.
It is recommended that you receive your BOTOX® treatments for migraines 12 weeks apart.
Book your initial assessment to see if BOTOX® Treatment is right for you.

Aimovig

How does Aimovig work?

In your body you have CGRP (calcitonin gene-related peptide) and CGRP receptors. CGRP attaches to and activates the receptor, which may play a key role in migraines. Aimovig blocks the CGRP receptor so that CGRP cannot attach to it. Aimovig is the first and only migraine preventive treatment designed to block the CGRP receptor.